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ABSTRACT 
Background: Due to individual health-related and social consequences, but also due to its 
immense cost burden, obesity remains a large public health challenge for which effective and 
cost-effective prevention is lacking. It has been suggested that primary preventive efforts 
operate optimally if started in early childhood, but scientific evidence is scarce. Optimal target 
groups and intervention programs are most likely to vary by structure of society, population 
characteristics, health care resources and many other factors.  
Aims: The primary aim of this thesis is to evaluative the effectiveness and cost-effectiveness 
of a primary prevention programme addressing childhood obesity at Swedish child health care 
centres (CHCs). A secondary aim was to increase understanding of the association between 
health-related quality of life (HRQoL) and body mass index (BMI), which will be useful for 
future health economic evaluations. 
Methods: Study I provides a description of the PRIMROSE intervention study, which includes 
a relative validation of a semi-quantitative food frequency questionnaire. Study II is based on 
repeated self-reported BMI and HRQoL measurements from the Stockholm Public Health 
Cohort. Study III is a main effect evaluation of the PRIMROSE cluster RCT, which includes 
1148 children at follow-up. Study IV is a systematic narrative literature review that explores 
the methods and applications of economic evaluations within the field of childhood obesity. 
Study V is a trial-based economic evaluation of the PRIMROSE intervention from a societal 
perspective. 
Results: Compared to normal weight, overweight and obesity was found to be associated with 
lower HRQoL, especially in the domains of mobility, self-care and usual activity. Heavy 
weight gain over eight years was also associated with lower HRQoL, whereas weight loss had 
no protective effect. The PRIMROSE intervention had no significant effect on BMI, waist 
circumference, obesity prevalence and objectively measured physical activity. Small 
intervention effects were found in dietary habits but should be interpreted with caution given 
the possibility of bias in assessments. Study IV showed that there were only a few health 
economic evaluations of childhood obesity, but these presented already small intervention 
effect to be worth the money. However, cost-effectiveness was largely dependent on model 
assumptions and, in particular, on decision-maker’s willingness to pay. The economic 
evaluation presented in Study V showed that PRIMROSE cannot be considered cost-effective 
given uncertainty around the effect measure.  
Conclusion: There was no evidence for the effectiveness or cost-effectiveness of the 
population-based PRIMROSE RCT. Since the prevalence of childhood obesity remains high, 
further research is needed to disentangle the “failure” of intervention programs per se from 
“failure” of implementation and “failure” of evaluation. 
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1 INTRODUCTION 
 
Childhood obesity is one of the biggest public health challenges of our time, and primary 
prevention in early childhood may be the most (cost-) effective approach to it. Yet in practice, 
little is known about the effectiveness and cost-effectiveness of primary prevention at preschool 
ages. Indeed, the last decade of empirical research points in a negative direction: primary 
prevention of early childhood obesity does not seem to work. How can it be that something 
that should work in theory does not work in practice?  
 
In 2008, when the PRIMROSE intervention study commenced, even less was known. Obesity 
prevalence was at an all-time high, and childhood obesity was a growing concern for health 
professionals and policy makers alike. At the same time, motivational interviewing (MI) was 
on the radar of health promotion. Could a technique used for the treatment of addictions also 
work as a component of obesity prevention? 
 
The primary care setting was suggested as a promising intervention arena for obesity 
prevention, but was at that time largely underutilised. In Sweden, almost all families attend a 
child health care centre (CHC) for preventive health care services. However, the focus is mainly 
on general growth and the provision of vaccination, and only to a lesser extent on young 
children’s developing food habits or physical activity. Since nurses reach families to take up 
vaccination plans, can we also reach families to follow healthy eating and physical activity 
behaviour in this setting? 
 
But even if a well-designed intervention became successful in the CHC setting, would it be 
worth the money? With unlimited needs and scare resources, decision-makers need additional 
information on how to allocate their money. In order to answer this question, we do not only 
need data on the costs of implementing an intervention, but we also need to capture all its 
effects, including societal savings. And how do we do that in the field of early childhood 
obesity prevention, where the vast majority of positive effects are expected only far into the 
future? 
 
This dissertation aims to address these issues by presenting the methods and results of a large 
population-based cluster randomised controlled trial (RCT). The following chapters provide 
not only summarising but also additional information on background, methodology, and main 
results in the included papers. The last chapter is a discussion of methods and results of the 
thesis, which are placed in the context of current research.  
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2 BACKGROUND 
In the following section, I will introduce the main themes of the thesis, including childhood 
obesity, primary prevention, and decision-making in public health. 
2.1 CHILDHOOD OBESITY 
2.1.1 Definitions 
The World Health Organization (WHO) defines obesity as “abnormal or excessive fat 
accumulation that may impair health” [1]. Although not as sensitive as some other 
measurements, the most simple and common way to classify obesity and overweight is the 
body mass index (BMI), which refers to a person's weight in kilograms, divided by the square 
of his or her height in meters (kg/m2). According to an international classification, a BMI 
greater or equal to 25 but below 30 denotes overweight, while a BMI greater or equal to 30 
denotes obesity [2]. 
These cut-offs are, however, not applicable to children, because children’s BMI normally 
develops over time, with a rapid increase in the first year, followed by a decline up to the age 
of 5-6 years, and then a gradual increase until adulthood. To take into account development 
over time, BMI-cut offs for children need to vary by age and gender. The most widely used 
definition of childhood obesity has been established by the International Obesity Task Force 
(IOTF) which corresponds to adult cut-off points for overweight and obesity at the age of 18. 
Yet, cut-offs decrease between 2-4 years of age and then gradually increase from ages 5-6 until 
age 18, where adult cut-offs are used [3]. An alternative is the WHO standard, which is used 
for children up to 59 months of age and based on a sample of healthy breastfed children from 
six countries (Brazil, Ghana, India, Norway, Oman, and the USA). The WHO standard defines 
overweight as > 2 standard deviations above the WHO growth standard median [4]. A study 
using a sample of Czech children found that these two different approaches led to different 
classification, especially among pre-school girls, where, according to the IOTF, 15% were 
classified as overweight compared to 3% using the WHO standard [5].  
2.1.2 Prevalence 
Starting in the 1980s, overweight and obesity prevalence rapidly increased; for children at the 
age of 10, the increase was up to 4-5 times until the early 2000s [6]. During the last decade the 
prevalence of overweight and obesity in children has stabilised with some indications of a 
levelling-off [7, 8]. A review from Sweden showed that there was a stabilisation of overweight 
prevalence among school children 10-11 years of age (born during 1989–1995) [9]. The results 
from the analysis of the “BEST cohort” supported this observation, showing a stabilisation and 
decline from 1991 onwards among 8 year-old boys in the Gothenburg region [10]. For children 
under 5 years of age, there is no systematically collected nationwide data in Sweden. Based on 
several county-specific reports, however, it seems reasonable to conclude that large variations 
by region exist [8]. The latest yearly report on children’s health from Stockholm County, 
showed a decrease in overweight prevalence [11]. Among 4-year-old children born in 2011, 
8.1% were overweight, compared to 9.4% three years before. The prevalence of obesity in 4-
year-old children did not decrease but remained stable at 1.8%. Furthermore, there are large 
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differences in prevalence of overweight between the municipalities of Stockholm County, 
ranging from 6% in Lidingö to 16.9% in Skärholmen among 4-year-olds, indicating a strong 
social gradient in childhood obesity [11].  
2.1.3 Modifiable Risk Factors for Childhood Obesity 
Physical Activity and Sedentary Behaviour 
A lack of physical activity (PA) is known to be associated with several chronic diseases, 
including obesity. According to the WHO, it is recommended that children (5-17 years) spend 
at least 60 minutes per day in moderate to vigorous physical activity (MVPA) [12]. For the age 
group < 5 years, national recommendations only exist in Canada [13], Australia [14] and the 
UK [15], suggesting at least three hours (180 minutes) of age-appropriate physical activity at 
any intensity level (i.e., light, moderate, vigorous). In the papers referred to, there are 
descriptions of what age-appropriate types of activity are. For example, for a toddler, activity 
is described as “any activity that gets the kids moving”, including climbing stairs or playing 
outside. Yet, intensity and time duration are only described, and not further specified.  
As well as lack of physical activity, there has also been an increase in time spent sedentary. 
Sedentary behaviour is defined as “any waking behaviour characterised by an energy 
expenditure ≤ 1.5 METs while in a sitting or reclining position” [16], and includes sitting, 
watching TV, or playing with electronic devices [17]. Over the last decades, there has been a 
sharp increase in sedentary behaviour in Westernised societies, which is often associated with 
changing demands in the workplace and increases in screen time [18]. Similar trends have been 
seen among children. Sedentary behaviour has been associated with a number of negative 
health outcomes. The question remains whether there are independent effects of sedentary 
behaviour on health outcomes, as there might be adverse metabolic and health effects of 
prolonged inactivity even if the recommendation for MVPA is met. A recent systematic review 
found no evidence for an association between sedentary behaviour and health outcomes in 
children after adjusting for MVPA [19]. Other studies have, however, shown contrasting results 
[20, 21]. Furthermore, the behaviours learned in early childhood may continue into adolescence 
and adulthood [22], where in turn sedentary behaviour is associated with adverse health events 
even when reaching the recommended level of MVPA [23]. A meta-analysis on the association 
between physical activity and sedentary behaviour has shown that the two are significantly 
inversely associated (r=-0.108, 95% CI: -0.128; -0.087). However, this rather weak association 
indicates that physical activity and sedentary behaviour can coexist, and do not necessarily 
replace one other, and may therefore need to be targeted separately [24]. 
Dietary Intake and Eating Habits 
When we think of the underlying cause of obesity, i.e., energy intake exceeding energy 
expenditure, the importance of dietary intake for obesity development is undebatable. Yet, the 
knowledge and evidence base surrounding energy intake, diet composition, and intake of 
certain food items, on the one hand, and later overweight in children, on the other, is not fully 
revealed. This can be partly explained by the methodological challenges measuring eating 
habits and dietary intake [25]. The only sound evidence for a risk of weight gain and obesity 
has been seen with sugar-sweetened beverages [26]. High intake of fruits, vegetables, and fish 
has been associated with a lower risk of a number of diseases [27], but the evidence base for 
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an isolated effect on childhood obesity remains inconclusive [28]. Children’s food preferences 
and intake patterns are directly and indirectly influenced by their parents [29, 30]. There has 
been increasing awareness of the effects of eating behaviours beyond the intake of certain food 
items, e.g., regular family meals. Other parental influences, including pressure by parents to 
eat (e.g., finishing the plate) or food as a reward have been also associated with food choices 
[31] and possibly later obesity [32]. 
Other Factors 
There is a growing body of research focusing on identifying early determinants of obesity [33], 
where the prenatal and the early postnatal periods have been suggested to be “critical periods” 
for the development of obesity [34]. The term critical period stems from the field of life-course 
epidemiology, describing limited time periods in which an exposure has an adverse or 
protective effect on future health outcomes [35]. Among others, these include maternal pre-
pregnancy weight [36], maternal socio-economic position, high gestational weight gain [37], 
gestational diabetes, smoking during pregnancy [38], high birth weight [39], rapid weight gain 
during the first year of life [40], no or short duration of breastfeeding [41], early introduction 
of solid foods [42], and short sleep duration [43]. 
2.1.4 Consequences of Childhood Obesity 
Health Consequences 
Once people develop overweight or obesity, they are at higher risk of developing chronic 
disease conditions, such as cardiovascular diseases [44], diabetes [45], musculoskeletal 
disorders [46], and some types of cancer [47]. Children with overweight and/or obesity not 
only run an increased risk of becoming obese as adults [48], they are already in childhood likely 
to develop comorbidities, such as type-2 diabetes [49], hypertension [50], and glucose 
intolerance [51]. Furthermore, childhood obesity is associated with low self-esteem and can, 
due to stigmatisation and weight-related teasing, lead to symptoms of depression and 
(perceived) social rejection [52, 53]. Through the development of these co-morbidities, but 
even through obesity itself, health-related quality of life (HRQoL) may be significantly 
impaired [54, 55]. 
Societal Consequences 
As well as health-related consequences, obesity potentially has large societal consequences 
through direct and indirect costs. In Sweden, direct health care costs related to obesity have 
been estimated to exceed several billion SEK annually [56]. Additionally, indirect costs, 
including productivity losses associated with overweight and obesity (sick-leave, disability 
pension, death before retirement) and other types of exclusion from the labour market (e.g., 
stigmatisation), are estimated to exceed health-related costs [57-60]. A recent systematic 
review synthesised the results on lifetime costs due to obesity in childhood and adolescence. 
The mean total lifetime cost of a child or adolescent with obesity was estimated to be €149 206 
(range: €129 410 to €178 933), with the vast majority of the cost being due to productivity 
losses and, more specifically, income penalties [61]. Five of the 13 included studies were based 
on adults (≥ 18 years old), and only two studies, from Germany, were based on an early 
childhood sample [62, 63]. 
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While there have been serious attempts to quantify the economic and societal impact of 
adulthood obesity in a Swedish setting [60], the economics of early childhood obesity 
prevention and the long-term economic consequences of childhood obesity in Sweden remain 
insufficiently explored and evaluated.  
2.2 PREVENTION 
While there is a fairly good understanding of the physiological cause of obesity (energy 
imbalance between calories consumed and calories expended), the underlying reasons for this 
imbalance are multi-dimensional. Knowledge of genetic factors contributing to obesity is 
increasing. Yet, the almost doubled prevalence of obesity worldwide since the 1980s indicates 
that environmental factors (e.g., infrastructure, policies) and individual health behaviours (e.g., 
physical activity, sedentary behaviour, and dietary habits) and interactions between these 
factors play a vital role in the aetiology of obesity [28]. There is a need to identify feasible, 
sustainable and cost-effective strategies that can decrease the occurrence of childhood obesity 
in society. With the (possible) exception of gastric bypass surgery in adults, and possibly also 
in adolescents [64], there are currently no effective treatment options for obesity, which 
emphasises the need for prevention.  
2.2.1 Stages of Prevention 
Traditionally, there has been a differentiation between primary, secondary and tertiary 
prevention strategies, which can be implemented at both individual and population level. 
Primary prevention refers to interventions to prevent the occurrence of a disease before it 
develops [29]. Within primary prevention, some public health researchers further differentiate 
between primary prevention and primordial prevention, where the latter refers to preventing 
the emergence of risk factors. Primordial prevention addresses broad health determinants rather 
than preventing exposure at the individual level [30]. Secondary prevention aims at the early 
recognition (e.g., by screening) of disease to limit its occurrence, while tertiary prevention 
focuses on limiting the consequences of disease (i.e., treating existing symptomatic disease) 
[29]. With regard to the prevention of obesity, the boundaries between the levels of prevention 
may be less distinct, because overweight/obesity can be considered as both a symptom and a 
disease. An alternative form of classification has been suggested, differentiating between 
indicative prevention, selective prevention, and universal prevention [65]. Universal 
prevention refers to preventive efforts targeting the population at large. Targeting populations 
subgroups with a high risk set (e.g., defined by ethnicity, socio-economic group or income 
level) is considered as selective prevention and targeting individuals at high risk as indicative 
prevention [66]. Instead of regarding these types of classification as distinct, they can be seen 
as complementary, where the first addresses disease development and the latter the target 
population. 
2.2.2 Primary Prevention of Childhood Obesity 
Due to the health consequences of overweight and obesity and the lack of sustainable treatment 
options, primary prevention seems to be the best way to address childhood obesity in society. 
Dietary and physical activity habits are established early in life and become less malleable in 
later life [67]. Parental practices, feeding styles and availability of (un)healthy foods at home, 
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as well as parents’ nutritional knowledge, attitudes and health behaviours, are of major 
importance for young children’s emerging eating and physical-activity habits [68, 69]. Thus, 
primary preventive efforts are likely to operate optimally if started in early childhood. The 
involvement of parents in any primary prevention program, as “gatekeepers” for children’s 
access to unhealthy foods and as role models for their emerging dietary habits, is of key 
importance. It is also important that prevention studies are based on a theoretical framework 
because it becomes clearer whether and how they are working or not. Yet, interventions that 
are reported to be based on a theory have not been more effective than interventions developed 
without a theoretical framework. This may be explained by the fact that theories are not 
extensively applied in the development of interventions, or are not implemented appropriately 
[70]. 
Motivational Interviewing 
Motivational interviewing (MI) is an efficient and brief method that prepares people for 
behaviour change; it is characterised by client-centredness [71]. Eliciting and reinforcing 
motivation for and commitment to behavioural change are central to MI [71-73]. An MI 
counsellor’s function is not to convince or persuade clients (e.g., parents), but rather to enhance 
intrinsic motivation, thereby assisting their own decisions about behavioural change. In 
addition to increasing and maintaining motivation, MI also emphasises the person’s self-
efficacy, i.e., a person’s belief in his/her ability to succeed with a behaviour change. Reflective 
listening, shared decision-making, and agenda-setting are key components of MI, and 
counsellors are to be non-judgmental, empathetic, and encouraging [74]. 
MI appeared in the 1990s, not directly from theory but rather from clinical experience of useful 
practices in the fields of drug abuse and smoking. Yet, many theoretical influences in the 
development of MI can be recognised (Figure 1) [75].  
Figure 1 Theoretical Influences Contributing to the Development of MI, based on Söderlund [75] 
Social Cognitive Theory 
A well-established theory for understanding health behaviour is social-cognitive theory (SCT), 
which refers to the dynamic interplay between interpersonal factors, behavioural factors, and 
environmental factors [76]. In intervention research, application of SCT is often characterised 
by efforts to increase self-efficacy, its key concept [77]. Maternal self-efficacy is a closely 
related concept defined as a mother’s trust in her own capacity to influence her children’s health 
behaviour. It has been shown that maternal self-efficacy is positively associated with children’s 
healthy eating and physical activity [78]. 
Motivational 
Interviewing
Roger's Client 
Centred Counselling
Cognitive 
Dissonance 
Theory
Theory of 
Psychological 
Reactance
Bandura's Self-
efficacy Concept
Stages of Change 
Model
Self-
Determination 
Theory
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Effectiveness of Obesity Prevention Interventions in Pre-School Children 
Due to the difficulties mentioned above, the evidence base for primary prevention of childhood 
obesity remains weak. Although a Swedish systematic review of the prevention of childhood 
obesity found some evidence that programs in schools and day-care settings, aimed at 
promoting healthy eating habits and physical activity, can prevent childhood obesity [79], other 
systematic reviews have shown no evidence [80-82].  
In 2011, a Cochrane review on childhood obesity prevention intervention was published 
including 55 randomised intervention studies. However, the majority of the included studies 
were conducted in school settings with children aged 6- to 12-year. Only eight of the studies 
included children younger than 5 years old, and in seven of these studies children were at least 
3 years old at baseline [83]. Although acknowledged as a promising intervention arena, there 
have been only few attempts targeting preschool children in the primary health care setting [83, 
84].  
2.3 DECISION-MAKING IN PUBLIC HEALTH 
2.3.1 Evidence-based Decision-Making 
Randomised Controlled Trials 
Randomised controlled trials (RCT) are regarded as the gold standard for assessment of the 
efficacy of interventions. By randomly assigning individuals to an intervention or control 
group, the risk of bias is minimised, allowing causal interpretation of the results. While the 
application of RCT in a clinical setting is fairly straightforward, the use of RCT in a public 
health setting, especially in the case of interventions based on behavioural change, faces some 
difficulties. These difficulties are mainly due to the complex causal processes in public health 
interventions as well as issues concerning ethics and feasibility [43]. Loss to follow-up, a lack 
of blinding, and cross-over between groups are some of the reasons why internal validity often 
cannot be assured. This makes it difficult to differentiate between failure of an intervention per 
se and failure of intervention implementation [44]. And, even in cases where internal validity 
seems to be good, it remains to be considered whether findings can be implemented in real-life 
settings.  
Cluster Randomised Controlled Trials 
Even though the RCT is the most efficient design to study causal relationships, in some 
instances randomisation at individual level is impractical or inadequate. A cluster RCT is a 
sub-type of RCT, in which randomisation is not performed at individual level but instead at 
group (i.e., cluster) level. Cluster RCTs are preferred where the intervention is delivered at an 
organisational level or unit (e.g., a CHC,) or cannot be directly targeted at individuals (e.g., 
school class room), or intervention “contamination” is to be expected. One disadvantage of the 
cluster RCT design is the need for more study participants to reach the same statistical power. 
Furthermore, due to the correlations within clusters other, more advanced, statistical methods 
are required to correct for the dependence between observations.  
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Pragmatic Trials 
Pragmatic trials, often embedded in routine practices, “have gained momentum” over the last 
decades [45]. In contrast to classical (sometimes referred to as explanatory) trials, that measure 
the efficacy of an intervention, i.e., the effect an intervention generates under ideal 
circumstances, a pragmatic trial measures effectiveness, i.e., the effect an intervention 
generates in real-life practice. Pragmatic trials often have a less stringent design which may 
decrease internal validity. Yet, pragmatic trials are assumed to provide higher external validity 
in terms of applicability and generalisability. The distinction between these two types of trials 
is not straightforward. Instead of dichotomising them, pragmatism can be seen as a continuum, 
where any one prevention study may have a certain degree of pragmatism in its design [85]. 
The degree of pragmatism may vary according to the research questions to be answered or to 
contextual factors hindering or facilitating implementation of a more stringent design. 
2.3.2 Cost-Effectiveness 
A high level of evidence should be the main driver of decision-making in health care. Yet, the 
costs of a new treatment and prevention programme cannot be neglected in any health care 
system. In fact, one of the three core principles of the Swedish health care system is the cost-
effectiveness principle, which states that the cost of health services should be reasonable from 
a medical, humanitarian and social-economic perspective [86]. Given the dilemma shared by 
all publicly financed health care systems, namely scarce resources with unlimited health care 
needs, prioritisation is necessary. Economic evaluations of existing and new treatment options 
can facilitate health care decision-making aimed at improving efficiency in the allocation of 
scarce resources. An economic evaluation may be defined as a “comparative analysis of 
alternative courses of actions in terms of both their costs and consequences” [87]. 
Types of Economic Evaluation 
It is common to differentiate between four types of economic evaluation: cost-minimisation, 
cost-effectiveness (CEA), cost-utility (CUA), and cost-benefit analysis (CBA). All four types 
of evaluation measure costs in similar ways and therefore differ mainly with respect to how 
(health) effects are measured (see Table 1).  
Table 1 Types of economic evaluation, adapted from Drummond et al. [87] 
Type of economic 
evaluation 
Valuation of costs Valuation of effects 
Cost-minimisation Monetary unit None (alternatives are assumed to have equal 
outcomes) 
Cost-effectiveness Monetary unit One-dimensional unit (e.g., BMI) 
Cost-utility  Monetary unit Multi-dimensional unit (e.g., QALYs) 
Cost-benefit Monetary unit Monetary unit 
Cost-effectiveness Analysis and Cost-utility Analysis 
A cost-effectiveness analysis (CEA) is one type of full economic evaluation where both the 
costs and the effects of health care interventions are considered. Both a CEA and a CUA 
assume that decision-makers strive to maximise gains in a health outcome subject to a cost 
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constrain [87]. The two types differ only with respect to the assessment of the health 
consequences. In a CEA the benefits are presented in a one-dimensional unit (e.g., life years 
gained), whereas in a CUA a generic outcome measure (e.g., quality-adjusted life years) is 
used, which allows comparison across disease areas [87]. 
Health-related Quality of Life 
Quality-adjusted life years (QALYs) provide a health-outcome measure that is constructed by 
adjusting life years for the quality of life in which they are spent. This represents an attempt to 
combine life expectancy and quality of life into a single measure.  
The term quality of life spans several interrelated disciplines, with health being one of the core 
element. The concept of HRQoL takes into account several dimensions of health and has been 
recognised as an increasingly important, as it goes beyond longevity and also acknowledges 
the subjective perception of disease and health [18]. Due to complex diseases and chronic 
disease management instead of the curing of disease, HRQoL becomes a measure that may be 
more accurate and appropriate in assessing someone’s health status. It further allows 
assessment of health effects before the consequences of symptoms and disease are physically 
manifested. A year spent in full health refers to 1 QALY (1 year of life x full (1) quality 
weight=QALY). Following the calculation, half a year spent in perfect years is equivalent to 
one year spent lived in a health state with a quality weight of 0.5. QALYs are calculated by 
multiplying life years by a weight representing the HRQoL of health status during those years.  
One instrument for measuring HRQoL is the EQ-5D. It has five dimensions, i.e., mobility, self-
care, usual activities, pain/discomfort and anxiety/depression with three response levels (1=no 
problems, 2=some problems, 3=severe problems) defining 243 health states [20]. Each health 
state can be converted into a single index, applying a so-called value set. Value sets are 
generated through one or more of the following three techniques: standard gamble, time trade-
off or visual analogue scale. While an experience-based value set exists for Sweden [21], there 
is currently no population-based value set available for the country. The values for the health 
states in the experience-based value set are assessed from real patients in the health states 
concerned. For the population-based value set, the general public values hypothetical health 
states.  
Measuring QALYs in Children 
While for adults HRQoL has been widely accepted as an endpoint in a research and clinical 
setting, the assessment of HRQoL among children has only gained awareness and interest in 
recent years. The assessment of someone’s HRQoL relies on his/her subjective evaluation of 
functioning/impairment in various domains, and it was believed that children’s subjective 
health reports were unreliable and therefore of limited use [88]. However, research indicates 
that school children (8-10 years of age) [89], and possibly even younger children [90], can 
adequately reflect and report their health state if instruments are adapted to them. Depending 
on the children’s age, HRQoL measurements may either be self-administered or administered 
by proxy (e.g., by parents). Due to young children’s incompletely developed cognitive and 
language skills, it is essential to rely on proxy respondents for the assessment of HRQoL in this 
age group. In a review, Griebsch and colleagues concluded that many aspects of QALY 
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measurement in children are not fully developed and therefore hinder their application in CUA 
[91].  
2.3.3 Decision-Making beyond Economic Evaluation 
As described above, decisions in public health should be based on the best available evidence, 
and provide the best value for money. But there are other additional factors that decision-
makers need to take into account when deciding on the implementation of public health 
interventions, which may not be directly quantifiable. The ACE-Obesity (Assessing cost-
effectiveness in obesity) working group developed so-called second stage filters to evaluate 
interventions beyond cost-effectiveness. These include the following criteria: “strength of 
evidence”, “equity”, “feasibility of implementation”, “acceptance by other stakeholders”, 
“sustainability”, and “side-effects” [92]. Primarily developed for the assessment of childhood 
obesity interventions, the criteria are also applicable to decision-making regarding other public 
health interventions.  
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3 AIMS 
3.1 OVERALL GOAL 
The overall objective of this thesis is to evaluate the effectiveness and cost-effectiveness of a 
large primary prevention programme addressing childhood obesity.  
3.2 SPECIFIC OBJECTIVES 
Specific objectives are to: 
1. Investigate the shape and strength of associations between overweight status, weight change 
and health-related quality of life. 
2. Describe the design and methodology of the PRIMROSE cluster-randomised controlled trial. 
3. Validate a semi-quantitative FFQ against a 7-day food diary. 
4. Evaluate the effect of the PRIMROSE intervention on 4-year-old children’s and their 
mothers’ BMI, dietary pattern and physical activity. 
5. Explore and review existing methods and applications of economic evaluations within the 
field of early childhood obesity prevention. 
6. Estimate the costs associated with implementation of the PRIMROSE intervention 
programme and conduct a trial-based cost-effectiveness analysis. 
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4 METHODS 
4.1 OVERVIEW 
 
Table 2 Overview of the studies included in this dissertation 
Evaluation Phase Study Design Materials Studies 
Pre-Trial Study Protocol PRIMROSE 
n=1039 
II 
Validation Study n=214 II 
Trial Cluster RCT PRIMROSE 
n=1148 
III 
Supplementary  
 
Cohort Study1 Stockholm 
Public Health 
Cohort 
n=16666 
I 
Systematic Literature 
Review 
Peer-reviewed 
articles 
n=6 
IV 
Post-Trial Cost-Effectiveness 
Analysis 
PRIMROSE 
n=1148 
V 
1 Study I was initially intended to inform Study V. However, instead of a cost-utility analysis, we conducted a trial-based cost-
effectiveness analysis. 
4.2 STUDY I 
4.2.1 Study Design 
Study I is a prospective cohort study with repeated measurements of BMI and HRQoL. The 
study was designed to investigate the associations between overweight, weight gain and 
HRQoL.  
4.2.2 Materials  
Stockholm Public Health Cohort 
The Stockholm Public Health Cohort (SPHC) provided the basis for a prospective study set up 
within the framework of the Stockholm Public Health Surveys coordinated by the Centre for 
Epidemiology and Community Health, Stockholm County Council. The cohort was initiated 
in 2002 and followed up twice (2007, 2010). The total population within Stockholm County of 
approximately 2 million makes it the largest and most densely populated county in Sweden. 
The cohort consists of individuals 18–84 years of age, who were selected using a stratified 
random sampling design from the total population of Stockholm County, with stratification for 
residential municipality. In 2002, 49 909 individuals were invited to respond to a questionnaire 
covering HRQoL, height, weight, socio-economic position, chronic diseases and disabilities. 
31 182 individuals took part in the survey in 2002. Of those, 23 794 (79%) also responded to 
the questionnaire in 2007, and 19 128 (61%) in 2010.  
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Record Linkage  
Using the unique personal identification number assigned to all residents in Sweden, the self-
reported data in the SPHC has been linked to several registers containing demographic and 
socioeconomic information, an also data from the National Patient Register and the Swedish 
Cancer Register. Since 1987, the National Patient Register has covered almost all inpatient care 
and since 2001 almost all specialised outpatient care in Sweden. Its quality was considered 
good in a recent evaluation, which found less than 1% underreporting [93]. Primary care, 
however, is not yet included in the Patient Register. Since 1958, the Swedish Cancer Register 
has information on all cancer cases in the Swedish population. The reporting of diagnosed 
cancer cases is compulsory. Underreporting is estimated to be less than 4% [94].  
4.2.3 Data Processing and Analysis 
For the first research question in Study I, on the overall relationship between overweight status 
and HRQoL, we pooled observations from 2002 and 2010. Overweight status was determined 
by BMI, which was calculated from self-reported weight and height, and categorised according 
to the international classification into underweight, normal weight, overweight and obese. 
HRQoL was measured using the descriptive system of the EQ-5D instrument, which has five 
dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression with 
three response levels (1=“no problems”, 2=“some problems”, 3=“severe problems”). A 
weighted summary index was calculated by using a population-based value set. In the absence 
of an appropriate Swedish population-based value set, the UK value set was used, as 
recommended [22].  
The following variables were considered as potential confounding variables and included in 
the models: smoking, mental health, chronic disease, civil status, highest attained education 
and occupational status. The cross-sectional association was analysed using generalised linear 
models with a Poisson distribution. Poisson distributions are usually applied to count data, but 
they can also be used for binary outcomes with a log link and robust variance to retrieve a direct 
estimate of relative risk instead of an odds ratio. This allows for easier interpretation [95]. To 
model the association between overweight status and the EQ-5D index as a continuous 
outcome variable, we performed linear regression with a generalised estimation equation 
(GEE) and adjusted standard errors.  
Table 3 Weight change categories between 2002 and 2010 
Category Cut-off 
Heavy weight decrease ≤ -10% 
Moderate weight decrease > -10% – < -5% 
Stable weight ≥-5% – 5% 
Moderate weight increase ≥ 5% – < 10% 
Heavy weight increase ≥ 10% 
For the second research question on the longitudinal association between weight change and 
HRQoL, we established weight-change categories, based on percentage weight change relative 
to baseline weight (Table 3). The same statistical analyses as described above were conducted. 
In addition to the above-mentioned covariates, an interaction term (weight change in 
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percentage * baseline BMI category) was included to analyse whether the effect of weight 
change differs with respect to baseline BMI category. 
4.3 STUDY II  
4.3.1 Study Design 
Study II is a protocol paper, which describes the design and methods of the PRIMROSE 
cluster RCT (Study III). This entails a (relative) validation study of a semi-quantitative FFQ.  
4.3.2 Materials 
PRIMROSE 
The design and methods of the PRIMROSE trial are described in detail in Study II. There 
follows a summary of its main aspects.  
PRIMROSE is a pragmatic cluster RCT, which was conducted at CHCs in eight counties 
(Stockholm, Uppsala, Södermanland, Örebro, Gävleborg, Västernorrland, Västmanland, and 
Jämtland) of Sweden. The trial commenced in 2008 and collection of follow-up data was 
completed in 2015. 1:1 Randomisation was performed at CHC-unit level, after nurses’ written 
consent to participate. During the recruitment period, there were about n=2 230 families with 
first-born children receiving care at the participating CHCs. Of those, 1 867 families were 
eligible. Families were not asked to participate if they did not speak Swedish, were about to 
move/change CHC, or had severe family situations making it unethical to ask them to 
participate in the trial. When children were 5–6 months of age, trial nurses approached eligible 
families, and n=1 369 agreed to participate.  
The intervention was based on SCT and involved 8 MI sessions led by trained nurses aiming 
to promote healthy eating and PA behaviours. During these sessions, parents, together with the 
nurses, formulated goals with regard to PA and healthy eating habits, which were then 
discussed in the following sessions according to the PRIMROSE manual (Figure 2). Families 
belonging to the control CHC units were offered regular routine health check-ups only. Of the 
601 families assigned to the intervention, 543 attended at least one session, and 388 took part 
in all nine sessions.  
 
Figure 2 Overview of the PRIMROSE Intervention  
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Validation Study  
To validate the FFQ developed for the PRIMROSE intervention, a separate study was 
conducted of a random population-based sample of families living in the same counties as the 
PRIMROSE population. Of the 2 400 invited families, 514 agreed to participate (21.5%). Of 
those, 68% completed the first food diary. The second food diary, which was sent to those who 
had filled in the first food diary, had a response rate of 78%. The FFQ was then sent to those 
families that completed at least one food diary. In total, 288 participants recorded their food 
intake for at least four days and answered the FFQ. The analytical sample for the validation 
study was restricted to mother-and-child pairs that completed both food diaries (8 days) and 
the FFQ (n=214). 
Table 4 Descriptive variables of children and mothers included in the validation study of the FFQ 
 N Mean sd Min Max 
Child age (years) 214 4.0 1.0 2.8 5.5 
Child BMI (kg/m2) 195 15.8 1.6 12.4 23.0 
Maternal age (years) 214 37.2 4.4 24.6 47.7 
Maternal BMI (kg/m2) 212 23.3 3.8 17.1 41.2 
4.3.3 Data Processing and Analysis 
To compare baseline characteristics between the intervention and control groups, t-tests for 
continuous variables and χ2-tests for categorical variables were performed. These were derived 
from unadjusted linear and multinomial regression models, with a robust (sandwich) estimator 
to take clustering into account. Standard statistical techniques are inappropriate for repeated or 
clustered data, since a key assumption (i.e., the assumption of homoscedasticity) is violated in 
a clustered RCT. By using the approach outlined above, we were able to estimate valid standard 
errors without requiring the usual assumption of the residual errors to have constant variance. 
Analyses of baseline characteristics can indicate whether randomisation has been successful, 
or whether there might be some selection bias. However, there is a debate over the statistical 
testing of baseline randomisation group differences [96]. In fact, according to the CONSORT 
statement, it is recommended that significance testing of baseline differences is not performed, 
since it may “mislead investigators and their readers” [97]. 
For the relative validation of the FFQ, mean and median frequencies of food intakes were 
calculated for both the FFQ and the food diaries. To analyse the agreement of the two methods 
of food intake assessment, Spearman rank-correlation coefficients were calculated, and 
interpreted according to widely accepted rule-of-thumb cut-offs [98] (Table 5). 
Table 5 Interpretation of strength of correlation [98] 
Very weak Weak Moderate Strong Very strong 
0.00-0.19 0.20-0.39 0.40-0.59 0.60-0.79 0.80-1.0 
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4.4 STUDY III 
4.4.1 Study Design 
Study III is concerned with main effects in the cluster RCT PRIMROSE. The design and 
methods of the PRIMROSE trial are described in detail in Study II, and the following will 
therefore focus on the data processing and analysis only. 
4.4.2 Data Processing and Analysis 
The primary outcome of PRIMROSE was children’s BMI at age 4. Measurements were taken 
by study nurses at all visits to the CHCs, but BMI was not always exactly measured at age 4. 
Therefore, we applied growth curve modelling, using non-parametric regression (kernel 
smoothing) to estimate children’s BMI at age 4 [99]. Secondary outcomes were mother’s BMI, 
children’s and mother’s food intake and PA. 
To evaluate the intervention’s effectiveness, both intention-to-treat and per-protocol analyses 
were performed. We did not perform any imputation of missing variables, and therefore did 
the ITT analysis only to the extent that missing values allowed (i.e., having at least the primary 
outcome measured at follow-up). In the per-protocol analysis, we restricted the sample to the 
families that completed the entire intervention, delivered by nurses who had completed their 
MI training.  
We ran unadjusted linear regressions on continuous variables and log binominal regressions on 
binary variables using generalised estimating equations with robust variance estimates, taking 
into account the cluster-randomised study design. 
4.5 STUDY IV 
4.5.1 Study Design 
Study IV describes a systematic narrative literature review designed to explore existing 
methods and applications of cost-effectiveness analyses in the field of early childhood obesity 
prevention. 
4.5.2 Materials 
The systematic review was conducted in line with the guidelines of the Centre for Reviews and 
Dissemination [100]. We searched for relevant articles published between 2004 and November 
2015 using the main electronic databases for health sciences and electronic evaluations 
(PubMed, Cochrane Library, NHS Economic Evaluation Database, and EconLit). Based on our 
research question, and key terms and articles identified beforehand, an independent librarian 
developed and applied a search strategy which led to n=728 articles. Based on title and abstract 
screening, 717 articles were excluded, leaving 11 articles for full-text screening. The final 
sample consisted of 6 studies. 
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Table 6 Inclusion and Exclusion Criteria 
Inclusion Exclusion 
Trial-based cost-effectiveness analyses, 
simulation/model-based cost-effectiveness 
analyses 
Reviews, meta analyses, qualitative studies, 
partial economic evaluations (i.e., cost 
descriptions), not peer reviewed 
Target population: Preschool children (<6 
years) and/or their parents 
Selected target groups (e.g., low SES, ethnic 
groups)  
Intervention: Behavioural intervention 
targeting dietary and physical-activity 
behaviours 
Pharmaceutical intervention, surgical 
intervention, structural intervention 
Intervention outcome measures must 
include at least one of the following: BMI or 
waist circumference, overweight prevalence 
 
Language: English or German No abstract available 
European countries, USA, Canada, 
Australia, New Zealand 
Developing countries 
4.6 STUDY V  
4.6.1 Study Design 
Study V is a trial-based economic evaluation of the PRIMROSE cluster RCT (Study III) 
performed from a societal perspective. 
4.6.2 Materials 
Study V is based on data from the PRIMROSE cluster RCT, which has been described earlier 
(see section 4.3). For Study V, we restricted the sample to the families that had completed the 
interventions (i.e., with available follow-up measurements). Average costs for the teaching and 
training of nurses and costs of intervention delivery were included.  
Table 7 Duration of visits and attendance among the intervention group that participated in at least one session 
(n=543) 
 Visit 1 Visit 2 Visit 3 Visit 4 Visit 5 Visit 6 Visit 7 Visit 8 Visit 9 
Type I G I I I T I T I 
Uptake 100% 93% 90% 86% 83% 75% 75% 65% 70% 
Length  65 min 84 min 52 min 53 min 51 min 24 min 51 min 22 min 50 min 
Visitor          
Mother 51% 56% 51% 53% 60% 86% 63% 84% 62% 
Father 3% 8% 10% 12% 5% 9% 10% 14% 11% 
Both  46% 36% 39% 36% 35% 5% 28% 3% 27% 
I=individual session, G=group session, T=telephone session 
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4.6.3 Data Processing and Analysis 
Costs and effects were estimated from participant-level data. The effect measure for Study V 
was children’s BMI at age 4, and based on the calculation described above in the section about 
Study III (section 4.4). The difference between groups was interpreted as BMI prevented.  
Costs were calculated for both the intervention and the control group. For the intervention 
group, costs included costs for education, training costs, and implementation costs. Based on 
invoices, training costs were calculated for one 5-day workshop, and then assumed to be similar 
for the other workshops. In order to estimate the costs for intervention delivery, data on the 
attendance and length of the individual sessions were recorded by the participating nurses 
(Table 7). This allowed us to estimate implementation costs for each participating family 
separately. Unfortunately, we did not collect any data on employment status and/or salary. 
Instead, we estimated salaries by using the age-specific average salaries for the regions 
provided by Statistics Sweden. Costs for the control group cover the regular check-up meetings 
only, and were estimated in the same way as in the intervention group. 
Cost-effectiveness was expressed by the Incremental Cost-Effeteness Ratio (ICER), which is 
calculated as follows: 
𝐼𝐶𝐸𝑅 =  
(𝐶1 − 𝐶2)
(𝐸1 − 𝐸2)
 
C1 = Costs in intervention group 
C2 = Costs in control group 
E1 = Effects in intervention group 
E2 = Effects in control group 
To indicate the level of uncertainty around the estimate, non-parametric bootstrapping was 
applied, where 1000 cost and outcome pairs were generated (with replacement) [18]. These 
results were then displayed on a so-called cost-effectiveness plane. A cost-effectiveness plane 
allows graphical representation of results and the uncertainty surrounding the estimate. Further, 
it allows a better interpretation of the ICER, since a negative value of the ICER can be both 
positive (lower costs with higher effects) and negative (higher costs with lower effects). The 
cost-effectiveness plane consists of a four-quadrant diagram, where the x-axis represents 
incremental effects, and the y-axis incremental costs. For quadrants IV and II, the choice 
between the interventions is clear. When intervention I is more effective and costs less than 
intervention II (quadrant II), it can be said that alternative I dominates alternative II. However, 
the vast majority of cost-effectiveness analyses present results in quadrant I, which means that 
a new intervention generates more health gains but at higher costs. In these situations, the 
choice is less clear and depends on the decision-maker and the willingness-to-pay (WTP). WTP 
is the maximum price a decision-maker is prepared (i.e., willing) to pay for a given outcome, 
and therefore regarded as a threshold for cost-effectiveness.  
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To shed light on the probability of cost-effectiveness, the results were then illustrated by using 
cost-effectiveness acceptability curves (CEACs), in which the probability that the PRIMROSE 
intervention is cost-effective was displayed for different theoretical WTP levels for the 
prevention of 1 BMI unit. 
 
4.7  ETHICAL CONSIDERATIONS 
Ethical Approval 
All studies included in this thesis have been approved by the Ethical Review Board in 
Stockholm, Sweden. 
Ethical Concerns with the SPHC 
For Study I which is based on data from the Stockholm Public Health Cohort, we do not see 
any substantial ethical issues. The participants in the SPHC consisted of a random sample of 
individuals aged 18–84 years living in Stockholm County. Invitations to participate were 
sampled from the Register of the Total Population, stratified by residential municipality. 
Participants gave their informed consent to the use of their national registration numbers and 
future contacts, and record linkages.  
Ethical Concerns with the PRIMROSE Intervention Study 
Parents provided written informed consent and were informed that they could leave the study 
at any point in time without giving a reason. Since the children were only 6 months of age when 
families were approached by our study team, parents also consented on behalf of their children. 
Although it seems very unlikely that taking part in the study has had adverse effects on 
participating parents and children, one possible adverse effect concerns additional stress for 
participating families. The first months/years after the birth of a child are a vulnerable time for 
parents. To avoid an additional burden for first-time parents, only families without severe social 
difficulties or severe health constraints were approached for dialogue about participation. 
However, even families without any social/health constraints can feel insecure, and by creating 
Figure 3 Cost-effectiveness plane, based on 
Drummond [32] 
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awareness of a potential harmful health behaviour, it cannot be ruled out that parents might feel 
ashamed, or even more insecure, about their own behaviour or parental skills. During the 
intervention period, parents were offered constant reflection over their own behaviour and 
guidance on how to promote healthy behaviour. Therefore, we believe that the benefits of 
participation would outweigh (or prevent) the potential negative effects of participation. 
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5 RESULTS 
5.1 WEIGHT CHANGE AND HEALTH-RELATED QUALITY OF LIFE 
Adjusted pooled linear regression analysis showed that people being overweight or obese, 
respectively, had -0.015 (95% CI: -0.018; -0.010) and -0.039 (95% CI: -0.047; -0.031) lower 
EQ-5D indexes compared to those of normal weight. When looking at the specific domains, 
there were significant elevated risks of reporting problems in all but one domain (i.e., the 
anxiety/depression domain) among the overweight or obese compared to those of normal 
weight.  
From baseline (year 2002) to follow-up (year 2010), 54.7% of the cohort remained stable in 
weight (+/- 5%) while more than 30% gained more than 5% of their baseline body weight. 
Weight gain was significantly associated with lower self-reported HRQoL, which was visible 
in both in the respective domains and the overall weighted summary score and irrespective of 
the baseline weight category. Weight loss was not significantly protective for reporting 
impairments. In contrast, those who lost weight and were normal weight at baseline were up to 
three times more likely to report problems in the respective HRQoL domains compared to those 
who remained stable in their normal weight. Only among those who were obese at baseline, 
there was an indication that moderate weight loss can be protective. However, these effect sizes 
did not reach statistical significance.  
5.2 BASELINE CHARACTISTICS OF THE PRIMROSE STUDY POPULATION 
Of the 1 867 families eligible for participation, 1 355 (with 1 369 children) agreed to participate. 
After retrieval of informed consent and disclosure of group allocation, families received the 
baseline questionnaire prior to their first intervention meeting at the participating CHCs. Due 
to time delays, not all (n=489 in the intervention group and n=550 in the control group) mothers 
filled in the baseline questionnaire prior to the first (intervention) meeting. The baseline data 
of those who submitted the baseline questionnaire late are not considered in the present analysis 
(n=46 in the intervention group and n=87 in the control group). In total, the baseline sample 
consisted of 1 039 mothers with 1 053 children. When comparing the groups, we did not find 
any statistically significant group differences with the exception of country of birth. Even 
though not statistically significant, the proportion of women in the intervention group with a 
university education was 7% larger than in the control group, which may indicate some 
selection bias. With regard to diet and physical activity, mothers in the two groups were similar. 
Only for sugared drinks and snacks (discretionary calories) did participating mothers in the 
intervention group have a lower, although not statistically significant, reported food intake 
compared to mothers in the control group. 
5.3 VALIDATION OF THE FOOD FREQUENCY QUESTIONAIRE 
Spearman correlation coefficients varied from weak (e.g., fish and French fries intake) to strong 
(e.g., mother’s fruit intake) (Table 8). In general, there was a systematic increase in differences 
(both positive and negative) between the two methods with increasing intake. Furthermore, 
mothers with normal weight, compared to mothers with overweight, tended to be more accurate 
in the reporting of their own and their children’s intake. 
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Table 8 Relative Validation of a Food Frequency Questionnaire 
 
Food diary and FFQ 
n d†  95% CI r 95% CI 
Children       
Fruits (t/d) 210 0.30 0.19; 0.42 0.42 0.31; 0.53 
Vegetables (t/d) 212 1.08 0.96; 1.19 0.48 0.36; 0.58 
Fish total (t/w) 211 0.54 0.33; 0.74 0.31 0.18; 0.42 
French fries (t/m) 210 0.14 -0.12; 0.40 0.36 0.24; 0.48 
Sugared drinks* (t/w)  211 -0.39 -0.65; -0.13 0.59 0.50; 0.67 
Discretionary calories** (t/w) 212 0.75 0.18; 1.33 0.56 0.46; 0.65 
Mothers      
Fruits (t/d) 213 0.48 0.37; 0.59 0.60 0.50; 0.68 
Vegetables (t/d) 213 1.44 1.29; 1.59 0.32 0.19; 0.43 
Fish total (t/w) 205 0.36 0.13; 0.60 0.41 0.28; 0.51 
French fries (t/m) 211 0.23 0.00; 0.46 0.34 0.22; 0.46 
Sugared drinks* (t/w)  209 -0.13 -0.37; 0.11 0.43 0.32; 0.54 
Discretionary calories** (t/w) 198 0.19 -0.45; 0.83 0.52 0.41; 0.61 
r=Spearman correlation, t=times, d=day, w=week, m=month, CI=confidence interval, *sugared drinks include soda with sugar 
or lemonade, and chocolate drinks); **discretionary calories include savoury snacks, sugared drinks, sweets, chocolate, pastries, 
cake and ice cream; † Difference between mean (FFQ) and mean (FD). 
5.4 MAIN EFFECTS OF THE PRIMROSE INTERVENTION 
At follow-up at age 4, there were 1 148 children with data on weight and height. Mothers who 
were pregnant at follow-up were excluded (n=82). There were no statistically significant group 
differences in BMI (mean difference: -0.11, 95% CI: -0.31; 0.08) or waist circumference (mean 
difference: -0.48, 95% CI: -0.99; 0.04) in the intention-to-treat analysis. In the per-protocol 
analysis, where the analytical sample was restricted to families who had completed all sessions 
with nurses (and who had also completed their full training programme (n=1 088)), the results 
for BMI and overweight prevalence remained virtually the same, whereas the results for WC 
reached statistical significance. 
For the secondary outcomes, there were small, yet significant intervention effects with regard 
to the intake of some of the food items, i.e., vegetables, French fries, sugared drinks and 
discretionary calories (Table 10). There was no evidence of an intervention effect with regard 
to physical activity and sedentary behaviour (data shown in Study III). A similar pattern was 
observed for mothers. There were also no intervention effect on mother’s BMI, WC, or PA 
(data shown in Study III). 
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Table 9 Primary Outcome of the Primrose Intervention: Results from the Intention-to-treat and Per-Protocol 
analyses 
 Intervention  
(n=448) 
Control  
(n=700) 
  
Intention-to-treat Mean (se) Mean (se) Mean Δ/RR (95% CI) p-value 
Children     
BMI (kg/m2) 16.0 (0.08)  16.1 (0.06) -0.11 (-0.31; 0.08) 0.26 
Waist circumference (cm) a 52.5 (0.21) 53.0 (0.26) -0.48 (-0.99; 0.04) 0.07 
Overweight b (%) 14.8 (0.02) 15.5 (0.01) 0.95 (0.69; 1.32) 0.78 
 Intervention  
(n=388) 
Control  
(n=700) 
  
Per-Protocol Mean (se) Mean (se) Mean Δ /RR (95% CI) p-value 
Children     
BMI (kg/m2) 15.9 (0.10)  16.1 (0.08) -0.15 (-0.35; 0.54) 0.15 
Waist circumference (cm) c  52.4 (0.24) 53.0 (0.16) -0.63 (-1.19; -0.70) 0.03 
Overweight b (%) 14.5 (0.02) 15.5 (0.01) 0.93 (0.66; 1.64) 0.70 
a missing: n=47, b including obesity, c missing: n=20 
Table 10 Intention to treat analysis of food habits at follow-up of children and mothers in the PRIMROSE trial 
 Intervention 
(n=412) 
Control 
(n=595) 
  
 Mean (se) Mean (se) Mean Δ (95% CI) p-value 
Children     
Fruits (t/d)a 1.1 (0.03) 1.1 (0.03) 0.01 (-0.09; 0.11) 0.78 
Vegetables (t/d)a 1.0 (0.03) 0.9 (0.03) 0.13 (0.04; 0.22) 0.01 
Fish (t/w)a 1.6 (0.06) 1.5 (0.06) 0.10 (-0.06; 0.27) 0.21 
French fries (t/m)a  1.5 (0.07) 1.8 (0.07) -0.37 (-0.58; -0.17) <0.001 
Sugared drinks (t/w)b 2.2 (0.18) 2. 7 (0.15) -0.49 (-0.97; -0.15) 0.04 
Discretionary calories (t/w)b 5.3 (0.17) 5.9 (0.12) -0.60 (-0.14; -0.25) 0.01 
t=times, d=day, w=week, m=month. Sugared drinks include soda with sugar or lemonade, and chocolate drinks; discretionary 
calories include savoury snacks, sugared drinks, sweets, chocolate, pastries, cake, and ice cream. a missing: n=5, b missing: 
n=14 
5.5 A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF EARLY 
CHILDHOOD OBESITY PREVENTION INTERVENTION 
Out of 728 studies that were identified, only six were in line with our inclusion and exclusion 
criteria. Even though one study did not report any results, it did present the methods of a full 
economic evaluation and was therefore included. None of the economic evaluations were based 
on interventions that reported significant effect sizes. Yet, three of them still reported cost-
effectiveness (Table 11). Three main conceptual and methodological limitations of economic 
evaluations were identified: an insufficient conceptual approach considering the complexity of 
childhood obesity, inadequate measurement of effects of interventions, and a lack of valid 
instruments to measure the child-related quality of life and costs. 
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Table 11 Characteristics of the studies included 
CEA=cost-effectiveness analysis, CCA=cost consequences analysis, n.a= not applicable 
5.6 ECONOMIC EVALUATION OF THE PRIMROSE INTERVENTION 
The estimated mean total costs per participant in the intervention group were 453 Euros 
(Min=177, Max=740) in comparison to 111 Euros (Min=0, Max=246) in the control group for 
usual care. The mean additional costs for carrying out the intervention programme were 342 
Euros (95% CI: 334; 348) per participant. The main costs were costs of the education, costs of 
MI training and supervision, and costs of implementation of the intervention program. The 
largest component of the PRIMROSE costs arose from delivery of the intervention within the 
CHC settings. The point estimate of the incremental cost effectiveness ratio (ICER) was 3 109 
Euros per 1 BMI unit prevented. About 11% of the bootstrapped pairs were dominated, 
meaning that the PRIMROSE intervention costs more for less effect. Yet, the vast majority of 
the bootstrapped ICER estimates indicate increased benefits and greater costs. Given the 
uncertainty around the effect measure combined with considerable opportunity costs, the 
current trial-based economic evaluation of PRIMROSE suggests that resources might be better 
used elsewhere within the field of obesity prevention.   
Authors Type Study 
perspective 
Time 
horizon 
Effectiveness 
Mean Δ  
(95% CI) 
Cost-
effectiveness 
Moodie et 
al. 
CEA Societal Lifetime -0.25  
(-0.62; 0.12) 
Yes 
Wake et 
al. 
CCA Reported:  
Health care 
Assumed: 
Societal 
Short  
(1 year) 
-0.00 
(-0.50; 0.50) 
No 
Ma and 
Frick 
 Not reported 
Assumed:  
Health care 
Lifetime n.a. n.a. 
Moodie et 
al. 
CEA Societal Lifetime  -0.28  
(-0.70; 0.15) 
Yes 
Hayes et 
al. 
CEA Health care Short  
(2 years) 
0.33  
(-0.04; 0.66) 
Yes 
Pil et al. CEA/ 
Design 
Societal Lifetime n.a. n.a. 
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6 DISCUSSION 
In what follows, I summarise the main findings of our research, discuss limitations and the 
findings in light of current discourse and ways ahead, with regard to both childhood obesity 
prevention in general and more specifically the analysis and (economic) evaluation of 
intervention studies within the field. 
6.1 MAIN FINDINGS  
1. Weight gain was significantly associated with lower HRQoL (Study I). 
 
2. There was no preventive effect of weight loss on HRQoL, irrespective of baseline 
weight (Study I). 
 
3. The FFQ showed moderate to good validity for the majority of food items (Study II). 
 
4. There was no significant intervention effect on children’s BMI at age 4 (Study III). 
 
5. There were small significant intervention effects on parent-reported intake of certain 
food items, but no effects on objectively measured physical activity (Study III). 
 
6. Despite a large and increasing number of intervention studies in early childhood, few 
have evaluated economic aspects (Study IV). 
 
7. Even small intervention effects can give value for money, but this depends largely on 
model assumptions and the decision-makers’ willingness to pay (Study IV/V). 
 
8. Given the uncertainty around the effect measure, the PRIMROSE intervention 
programme cannot be considered as cost-effective (Study V). 
6.2 LIMITATIONS 
To be able to discuss the results from the studies, there is a need to look carefully at 
methodological issues and limitations. 
6.2.1 Study I 
In contrast to the RCT design that takes care of confounding by design, observational studies 
need to take confounding into account when analysing and interpreting the associations of 
interest. If there is information on all possible confounding variables and a sample large enough 
to include all covariates to make reasonably precise estimations, the causal impact can be 
estimated. Yet, in reality, this is often not the case. In the association between overweight and 
HRQoL, there are a number of factors that may explain (parts of) the observed association. 
Some may be on the causal pathway, mediating the association of interest. Others may 
moderate the association, meaning that the effect can be amplified or weakened. And again, 
some factors may confound the association, i.e., influence both the dependent and independent 
variable thereby giving a spurious association. A plausible confounder of the association 
between overweight status (or weight change) and HRQoL is (chronic) disease status. Certain 
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chronic diseases (e.g., cancer) are known to decrease weight at late stages. In addition, there 
are other diseases, e.g., psychiatric disorders that are treated with psycho-pharmacological 
drugs, which result in weight gain and thus overweight. At the same time, having a chronic 
disease will most likely influence a person’s subjective perception of HRQoL. By lacking 
information about chronic disease or failing to take such information into account, associations 
may be over- or under-estimated. In the current study, we tried to address this issue by first 
excluding those with self-reported chronic disease at baseline and then by including self-
reporting chronic disease as a covariate in the statistical analyses. However, we could not fully 
differentiate between intended and unintended weight change.  
Another common problem with cohort studies is selection bias due to differential non-response 
or drop-out. A majority of studies indicate that non-responders have higher morbidity and 
mortality than those responding to surveys. Indeed, in our sample, we saw that people who 
were lost to follow-up reported a lower HRQoL at baseline. Differential non-response bias 
regarding questions on weight and height may also occur. In our analysis, we excluded people 
who had missing information on the questions of weight and/or height. Again, the response 
pattern may be determined by weight status, meaning that people with overweight or obesity 
are less likely to respond to weight-related questions than those of normal weight. In addition 
to differential non-response bias, our analyses may be further biased by differential 
misclassification. People with overweight and obesity are more likely to underestimate their 
weight and overestimate their height in comparison to normal-weight individuals [101]. 
6.2.2 Study II  
Validation studies are intended to provide information on how well an instrument measures 
what it is supposed to measure. Ideally, in validation studies, we compare our instrument of 
interest to a so-called gold standard, i.e., the instrument that provides a true measure of 
condition or phenomenon of interest. For the assessment of dietary intake or eating patterns 
there is, however, no true gold standard available, and almost all traditional methods rely on 
self-reported (or proxy-reported) information. The most common are 24-hours food recall, food 
frequency questionnaires (measuring types and amounts of food, and also intake frequency) 
and food diaries. Yet, food diaries can be burdensome and scarcely possible to maintain with 
large samples of individuals. Furthermore, research has indicated that the actual process of food 
recording may even alter people’s food intake. A prominent other method, especially in large 
cohort studies, is the FFQ, often in semi-quantitative form. It includes questions on a battery 
of food and beverage items regarding intake frequency and portion sizes. Due to the above-
mentioned lack of a true gold standard, validation studies in a strict sense cannot be conducted. 
Instead, the term relative validation (or validation) is used to describe a validation using 
imperfect reference instruments, comparative which is commonly performed in the field of 
nutritional epidemiology. Traditionally, food records have been believed to be more accurate, 
and the 7-day food diary is often used as the gold standard for validating other methods. Given 
the inherent limitation of this method, there is a need for care in interpreting the results. For 
example, our research indicates a good relative validity of fruit intake. This may indicate that 
our semi-quantitative FFQ accurately measures fruit intake. However, it may indicate 
alternatively that both instruments provide biased estimates to the same extent, and/or in the 
same direction, when assessing fruit intake.  
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6.2.3 Study III 
The RCT design is considered as the gold standard, and the only design that allows direct causal 
interpretation. Internal validity is therefore often warranted, despite the fact that more 
motivated and health-conscious people participate in these types of trials than those who are 
less motivated or health-conscious. External validity, also called generalisability, is, however, 
challenged by such self-selection into a RCT. Of the 1 007 nurses eligible to participate in the 
PRIMROSE trial, only 129 (12.8%) agreed to take part. A questionnaire among participating 
and non-participating nurses revealed some, albeit small, differences with regard to earlier MI 
education and specialist training. Among eligible families (n=1 867), more than 70% agreed to 
participate, which is considered a high proportion for this kind of intervention, where 
recruitment is often troublesome [102]. Of the 498 families declining to participate, 434 
(87.1%) did answer a brief anonymous questionnaire, indicating only small differences with 
regard to maternal age, country of birth and highest education. Still, the PRIMROSE population 
may not be entirely representative of the general Swedish population. Among the PRIMROSE 
sample, around 10% of first-time mothers were born outside Sweden, in contrast to almost 20% 
in the general population. This difference is explained by the eligibility criteria of the trial. 
Because of the structure and content of the intervention, participants needed to be proficient in 
Swedish, which may not have been the case for recently migrated families.  
Another limitation of the PRIMROSE intervention study concerns intervention delivery. As 
described earlier in detail, nurses received extensive education and practical training in MI prior 
and during the intervention period. Still, the vast majority did not reach beginning proficiency 
thresholds on any of the indicators of MI proficiency [103, 104]. This said, the proficiency 
thresholds used to evaluate MI skill levels are based on expert opinions only and have not been 
further validated. Also, there is no formal validation of the level of MI adherence needed to 
initiate a behaviour change among clients [105]. Yet, due to a possible lack of MI proficiency 
among nurses, we might have been unable to truly evaluate MI’s efficacy.  
The assessment of dietary intake and habits is known to be susceptible to biases, including 
recall bias and social desirability bias. Also, we found in our relative validation study that we 
were unable to capture all food intakes equally well. Parents (often mothers) filled in the FFQ 
for the questions, and we saw that children and mothers’ intake were correlated, which may be 
due to the fact that children at the age of 4 have meals together with parents and therefore were 
reported to eat similar food. It may, however, also reflect measurement error due to mothers’ 
being proxy reporters. If measurement error is systematic, e.g., resulting from social 
desirability bias, an overestimation of the intervention effect would be expected. Another 
limitation with regard to dietary assessment is a lack of data, as we only measure food intake 
consumed within the family. At follow-up, 95% of the children attended day care. However, it 
can be assumed that the access to and quality of food (in terms of composition) offered at day 
care centres will be the same for both the intervention and control group and should therefore 
only marginally have influenced our results. Furthermore, the focus of the intervention was on 
parental influences (especially mothers’ behaviours) and not behaviour change among day-care 
centre personnel. 
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6.2.4 Study IV 
The aim of the systematic review was not to pool estimates from individual studies to provide 
an overall estimate of cost-effectiveness, but rather to explore the scope, quality and variation 
of methodologies used within the field. If there had been the intention and capacity to pool the 
data, there would have been a need to be aware of publication bias. Considering the 
continuously increasing number of intervention studies within the field of early childhood 
obesity prevention, the small number of economic evaluation is somewhat surprising, but may 
reflect a lack of effectiveness and consequently lack of cost-effectiveness.  
6.2.5 Study V 
The main limitations of the economic evaluation of PRIMROSE are the lack of a significant 
intervention effect, a lack of HRQoL data for young children, limited costing data, and also too 
short a time horizon. 
CUA are often preferred as these allow decision-makers to make comparisons and set priorities 
across different health outcomes by having a common effect measure, e.g., a QALY. In order 
to calculate a QALY there is a need to measure HRQoL using a preference-based instrument, 
like the EQ-5D, which was not included in the baseline or follow-up questionnaire. Therefore, 
we conducted instead a trial-based cost-effectiveness analysis with BMI unit as effect measure. 
Another limitation is the restriction of the trial period, which means that effects and costs are 
limited to the observation period, i.e., up to 4 years of age. A longer time horizon is especially 
relevant to the evaluation of primary prevention interventions, where health effects and cost 
savings may only be visible in adulthood. Having too short a time horizon can potentially 
underestimate differences between the intervention and control groups. Additionally, we 
lacked information on the employment status and salaries of parents. Instead, we used region- 
and age-specific average salaries reported by Statistics Sweden to estimate the productivity 
losses due to participation in the trial. 
To capture possible savings of the interventions, it would have been desirable to have had data 
on participants’ health care utilisation. It can be argued that the majority of direct health-related 
cost savings will occur in adult age. However, a recently published Australian study indicates 
that, as early as in infancy, differences in health care utilisation can be detected between 
normal-weight and overweight children [106]. The health care costs of obese children were 
found to be 1.6 (95% CI: 1.12; 2.34) times those of normal weight children after adjustment 
for maternal characteristics and SES [106]. Failing to take these costs into account may lead to 
an under-estimation of cost-effectiveness. The PRIMROSE intervention addresses both parents 
(especially mothers) and their children. While keeping in mind the limitations in the assessment 
of dietary intake, there was an indication that mothers in the intervention group also had a 
slightly healthier food intake than those in the control group at 4-year follow-up. In economic 
evaluations, and in intervention research in general, one may further want to consider how to 
capture these or other spillover effects. Yet, so far, “current methods of cost-effectiveness 
analysis implicitly assume zero spill over among social ties” [107]. Younger siblings will most 
likely also benefit from this type of intervention. However, unfortunately, we did not collect 
information on whether families had further children and could therefore not explore this 
possibility.  
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6.3 THE NOVELTY OF PRIMROSE 
Today, the prevention of early childhood obesity is well-established and a growing research 
field. In 2006, when the PRIMROSE intervention study was developed, it was among the first 
to evaluate intervention in infancy. At that time, the majority of intervention studies targeted 
children in a school setting, and only a few looked at children in kindergarten. The primary 
care setting was suggested as an intervention arena of interest, but had been largely 
underutilised.  
PRIMROSE in turn was an intervention study closely embedded in a CHC setting with a design 
feasible to implement in public health practice. MI at that time was not yet evaluated as a way 
to convey intervention programs in the field of childhood obesity, either in a treatment or in a 
prevention setting. A well-established theory at the time was SCT for behavioural change. Yet, 
the majority of obesity interventions were not based on any theory, which was at that time 
believed to be a critical component of an intervention’s success.  
6.4 RELATION TO OTHER STUDIES 
The latest Cochrane review on early childhood obesity prevention is by Waters and colleagues 
from 2011 [83]. In that review, the authors looked at 55 studies including children under the 
age of 18. Their main conclusion was that interventions related to physical activity and nutrition 
have the potential positively to influence children’s BMI. However, the vast majority of studies 
had been conducted in school settings, and only eight looked at children under the age of five. 
Peirson and colleagues updated this review in 2015 with an addition of 62 studies [108]. In 
their meta-analysis they showed a small, yet significant overall effect (standardised mean 
difference=-0.07, 95% CI: -0.10; -0.03). Since the Cochrane review in 2011, interventions in 
early childhood have increased. Of the 20 interventions included for this age group, only one 
health promotion intervention, for Arab-Israeli, kindergarten children had a significant 
intervention effect [109]. Despite the increase in the number of interventions, the authors 
acknowledge a lack of studies for this age group. Until today, we are not aware of any other 
study that has examined early childhood obesity prevention in a health care setting, applying 
MI with the intensity and duration as the PRIMROSE intervention trial. Yet, there are a number 
of other related studies, which we will discuss below. 
6.4.1 Intervention Studies in Early Childhood 
A recent systematic literature review looked at interventions in the “first 1000 days” [110]. The 
authors identified 26 unique completed interventions, but none of them were found to be 
effective in preventing obesity or overweight with regard to prevalence. However, nine were 
effective with regard to small decreases in BMI, which may lead to the prevention of obesity 
if applied in larger populations. Of the 9 effective interventions, seven were based on 
individual- or family-level behaviour changes through counselling. However, the authors 
acknowledge that the results should be interpreted with caution given that only two [111, 112] 
of the included studies fulfilled all the quality criteria [110].  
6.4.2 Interventions Embedded in a Primary Care Setting 
At the time when PRIMROSE commenced in 2008, the primary care setting was considered a 
promising new and underutilised intervention arena [83]. Now in 2018, many more studies 
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have been conducted in that setting. Seburg and colleagues conducted a systematic review of 
primary care based obesity interventions that included both treatment and prevention 
interventions [113]. Of the 31 included studies, 8 had a significant effect on children’s weight. 
However, 7 of them were treatment studies. The one preventive intervention study focused on 
sleeping and feeding practices in the first year of life, and was based on assisting parents to 
differentiate between feelings of hunger and other forms of distress, on assisting parents with 
the introduction of solid foods, and on how to overcome barriers with regard to the introduction 
of healthy food items. At follow-up, infants in the intervention group had lower weight-for-
length percentiles than those in the control group [114].  
6.4.3 Interventions Studies using MI 
There is some evidence that MI is effective for treating obesity in adults [115]. But, in children, 
the evidence for a treatment effect of MI is mixed [116, 117]. The use of MI for prevention of 
childhood obesity is rare, but has been suggested as a promising approach [74]. For early 
childhood obesity interventions, MI is often directed towards parents only. We are aware of 
only one other study that applied MI as a counselling approach for the prevention of obesity in 
pre-school children age [118]. At follow-up at age 2-5 years the children in the “Healthy Habits, 
Happy Homes” intervention group had a (borderline) significantly lower BMI compared to the 
control group (-0.40, 95% CI: -0.79; 0.00). The intervention went on for about 6 months, and 
involved four MI sessions and four telephone calls by health educators [118]. Compared to the 
PRIMROSE intervention, the RCT had a more selective approach to prevention focusing on 
socially disadvantaged groups. Another Swedish intervention study used MI for the prevention 
of overweight and obesity among slightly older children (6 years of age) in a school setting, 
showing similar results to those of the PRIMROSE trial, i.e., no intervention effects on BMI 
and objectively physical activity behaviour (in boys), and small intervention effects on dietary 
behaviour [119].  
6.4.4 Intervention Studies Targeting Parents as Agents 
The components of the PRIMROSE intervention mainly addressed parents, based on the fact 
that they are role models in their children’s emerging health behaviours. Parent involvement is 
almost always involved in early childhood obesity prevention. The meta-analysis of Yavuz and 
colleagues focused on early childhood obesity interventions (both prevention and treatment) 
that included parents and identified 50 studies [120]. The overall effect size was small, but 
statistically significant. However, only 20% of the interventions included presented significant 
(short-term) effect sizes and none of the studies maintained their effect at later follow-ups 
[120]. Furthermore, the majority of the studies showing intervention effects that concerned 
treatment rather than prevention. Therefore, the overall significant effect size might have been 
driven by the treatment effect. 
6.5 THE ROLE OF OBESITY PREVENTION  
In theory, primary prevention of obesity should be the most effective way of addressing the 
global obesity epidemic. Yet, over the last decades, researchers have not been successful. The 
results of the PRIMROSE intervention are largely in line with other similar primary prevention 
interventions, showing, if any, only small effect sizes. This raises questions about how to take 
  37 
this important research field forward in the future. The main questions are at what age to start, 
who to target, and which intervention components to use. 
6.5.1 When to Start?  
The significance of early prevention has been widely acknowledged. As mentioned previously, 
behaviours contributing to the development of obesity are established early in life and become 
difficult to change once established. The gestational period has been identified as a critical or 
sensitive period for the development of offspring’s obesity [121]. A large body of evidence has 
demonstrated that gestational weight gain plays an important role in offspring’s birth weight 
[36], and weight trajectory in early childhood [122]. Therefore, the early childhood period may 
be too late to intervene, and there is a growing interest in interventions commencing already 
during early pregnancy to promote a healthy gestational weight gain [110]. Also, the 
preconception period has been suggested as a relevant period [123]. However, a Cochrane 
systematic review from 2015 that focused specifically on pre-pregnancy interventions for 
overweight or obese women did not identify even a single randomised trial [124]. An 
observational study from Canada showed that a 10% lower BMI is associated with a clinical 
meaningful risk reduction in a number of negative pregnancy outcomes [125]. However, so far, 
there has been no study that has investigated the effect of preconception weight reduction or 
overweight prevention on offspring’s development of overweight, but studies are on the way 
[126]. 
6.5.2 Who to Target?  
It has been suggested that the lack of evidence for prevention effects might be due to dilution, 
which may be due to targeting the general population [127]. The underlying assumption is that 
intervention effects are limited to those at highest risk and become diluted by targeting the 
general population. Another concern with interventions that target the general population is the 
possible widening of health inequalities, because low educated or poor families most in need 
of preventive measures may be least likely to take part in such interventions [128]. In addition, 
targeting the general population may give less health benefits for scare public resources than 
interventions targeting the most vulnerable groups. Therefore, targeting those most susceptible 
has been suggested to be potentially more effective than targeting the general population [18]. 
However, evidence from targeted intervention studies is sparse, and a concern with targeted 
intervention that has been raised is the potential stigmatisation of individuals [129][19]. 
Furthermore, Rose, many years ago, rightly pointed out that, once the underlying causes are 
known and controllable, “susceptibility ceases to matter” [130]. 
6.5.3 Which Components to Use? 
A lack of effectiveness may also be explained by focusing on wrong or less sufficient 
intervention components. The main focus of the PRIMROSE intervention was on physical 
activity and dietary habits. For early childhood obesity, it has recently been suggested moving 
beyond dietary habits and physical activity, and addressing other behaviours and determinants, 
e.g., children’s sleeping habits or stress in young families. Short sleep duration has been shown 
to be associated with an increased risk (RR: 1.45, 95% CI: 1.14; 1.85) of obesity among 
children [131], and other sleep patterns (i.e., routines) or late bedtimes may contribute to a 
higher risk of developing obesity among children [132]. Stress has also been suggested as an 
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important factor. Both stress in parents (or parents’ perceived stress) [133] and stress in early 
life (i.e., a lack of self-regulations skills [134]) are associated with an increased risk of obesity 
in childhood. 
However, it may not be enough to focus on individual obesity-related behaviours, as these are 
known to be shaped by upstream contextual social determinants, which operate beyond the 
individual level [135]. As early as in the 1970s, it was shown that obesity in children is strongly 
associated with parental socio-economic position [136]. Income, education and neighbourhood 
influence knowledge, motivation and the ability to engage in healthy behaviours [137]. 
Therefore, multi-sectoral interventions that focus on the root causes of obesity are necessary. 
These require a shift in responsibilities and a stronger political commitment in the fight against 
obesity.  
6.5.4 Implementation Issues 
One explanation for the absence of an effect of the PRIMROSE intervention might lie in 
difficulties related to implementation fidelity [138]. Bohman and colleagues showed that the 
nurses who participated in the intervention had not reached beginners’ proficiency in MI at the 
beginning of the intervention, when nurses had not yet received all supervision units [103]. 
Persson and colleagues analysed the sample once more after they received the full MI training 
programme and found only a marginal improvement in MI proficiency [104]. Process 
evaluation can help to further identify facilitators or hindering factors on the pathway between 
intervention and effects, and should ideally combine qualitative and quantitative research 
[139]. 
6.6 ANALYSIS AND INTERPRETATION OF INTERVENTIONS 
6.6.1 Intention-To-Treat Analysis versus Per-Protocol Analysis 
The validity of the RCT design may be challenged by non-compliance, protocol deviations, or 
dropout. Therefore, the CONSORT criteria suggest that RCT should be evaluated according to 
the intention-to-treat principle (ITT) to deal with non-random attrition [140]. In the ITT 
analysis, each randomised participant is included in the final analysis and is in the treatment 
group to which he/she is initially assigned, regardless of what happened after randomisation 
(e.g., cross-over or dropout). Results from ITT analyses show a more modest effect size, and 
acknowledge that non-compliance and protocol deviation may also occur in practice. However, 
ITT analyses are often challenged by a lack of outcome data. In addition to the results of an 
ITT analysis, it is often of interest to provide results from a so-called per-protocol analysis. A 
per-protocol (PP) analysis only includes participants who followed the protocol, and results 
provide therefore an indication of treatment efficacy. The CONSORT guidelines recommend 
that both ITT and PP analyses should be reported [140]. Yet, both types of analyses have their 
limitations, especially in the setting of health promotion interventions [141]. There is currently 
no consensus about how ITT should be performed in the absence of complete outcome data, 
and strictly speaking “no analysis with missing outcome data can be described as ITT” [142]. 
In order to not omit any participants from an analysis, missing values need to be imputed. In 
longitudinal data analysis, the “last observation carried forward” is still a widely used approach 
despite severe drawbacks of the method [143]. Another approach to dealing with the loss of 
follow-up is multiple imputation, which aims to account for some uncertainty in the estimates 
  39 
[144]. A variant of ITT analysis is the modified ITT, sometimes also referred to as complete-
case analysis, in which only subjects with available outcome measurements [145] are included. 
The basic assumption in providing a valid estimate is the “missing at random” or “missing at 
completely random” principle. However, there is currently no consensus regarding terminology 
and application of either ITT or modified ITT. The same difficulties apply with regard to PP 
analyses. Public health interventions are often complex by nature, and pragmatic trials in 
particular have a less stringent protocol. To strengthen analysis and reporting, an analysis plan 
should already be specified in the trial protocol. Furthermore, the reporting of trial results 
should include basic descriptive (baseline) variables comparing those who completed the trial 
to those who dropped out or were lost to follow-up. 
6.6.2 Defining Success in Obesity Prevention Interventions 
As mentioned above, the marginal and non-significant results of the PRIMROSE intervention 
with regard to BMI are, unfortunately, no exception and largely in line with other research in 
the field. Responses are two-sided. Whereas some argue that there is a need to “stop ineffective 
intervention” [146], another question concerns the concept of “success” in obesity intervention 
[147]. Is it reasonable to assume a BMI difference large enough to be detected when targeting 
the general population? Furthermore, in primary prevention, i.e., targeting those who are not 
yet overweight, we do not anticipate a BMI reduction, instead we would like to prevent 
unhealthy weight gain. Still, even in primary prevention interventions, individual BMI change 
is often the outcome measure of interest and a reduction in BMI units is interpreted wrongly as 
success.  
It is well acknowledged that BMI is not the gold standard for assessing body fatness. The gold 
standard for measuring body fatness is the double labelled water method [148]. This method 
is, however, fairly demanding and costly, and therefore not applicable for screening or larger 
studies. Alternatives are air displacement plethysmography, which has a higher reliability and 
validity than BMI, but is not as demanding as underwater measurement [149]. Still, for larger 
epidemiological studies, other “surrogate techniques”, including BMI, waist circumference, 
skinfold thickness, bioelectric impedance and hip-to-waist ratio are used to measure body 
fatness. Despite its limitations, BMI is still the preferred measure for capturing overweight and 
obesity. Especially in early childhood, the other measures may be of limited applicability in the 
assessment of obesity [150].  
In health promotion intervention studies “softer” end points are often used. Health behaviour 
(e.g., diet and physical activity) that are believed to be on the causal pathway act as end points 
for intervention studies. One underlying reason for this is that it takes time before a behavioural 
change becomes manifest in terms of BMI change, and also that a behavioural change is of 
benefit beyond what can be measured in BMI units. Still, behavioural change is still not 
necessarily needed in universal primary prevention, especially in early childhood where 
behaviours are to be learned and established. Therefore, a focus on broader behaviours with 
regard to physical activity and dietary behaviour may be a step forward.  
6.6.3 Economic Evaluations  
Due to the high prevalence of overweight and obesity, large amounts of resources are spent on 
treatment and prevention. Given the scarce resources faced by health-care systems, economic 
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evaluations are needed to assist decision-makers in prioritising and determining how and where 
to get the best value for money. Economic evaluations are well-established and fairly 
straightforward for pharmaceutical drugs and other therapeutic interventions. However, it 
becomes more complex for preventive public health interventions, where the vast majority of 
costs and benefits are in the far future and go beyond the health care sector. 
As described in Study IV, and also discussed by Frew and colleagues [151] in relation to the 
amount of intervention studies in the field of childhood obesity, the number of economic 
evaluations in that field is small. None of the 51 studies that were analysed in the latest 
Cochrane review from 2011 looked at the cost-effectiveness of the interventions [83]. In recent 
years, there has been a slowly growing number of cost-effectiveness analyses and a growing 
interest in the field. In Study IV we identified six studies, four of which were based on an 
individual intervention. 
To capture all possible costs and benefits, data from various sources (e.g., clinical, 
epidemiological, and economic) are needed. Trial-based economic evaluations, as in Study IV, 
give an underestimation and may be therefore of limited use. To account for future, preferably 
life-time, costs we need to model our analyses to account for variability and uncertainty [54]. 
However, results from modelling studies are only as good as the data input, and high-quality 
input data for the costs and benefits in the field of early childhood obesity prevention are sparse. 
Therefore, current model-based economic evaluations in the field of childhood obesity also 
have severe flaws. In addition, to extrapolate the benefits at the life-time horizon, data on effect 
maintenance are required from early childhood to adulthood. It is unreasonable to expect 
intervention studies to have follow-up measurement up to 15 years later, yet the assumptions 
that are currently often made (i.e., full effect maintenance) are not supported by research. 
Furthermore, more data are needed about direct and indirect costs that already occur in 
childhood, e.g., health care utilisation and educational attainment [151].  
6.7 IMPLICATIONS OF FINDINGS AND FUTURE RESEARCH 
The results of Study I suggest that even when obese individuals lose weight to reach normal 
weight, their HRQoL does not become the same as for those who have been normal weight all 
the time. While acknowledging the fact that the weight reduction may have been unintentional, 
there is also the possibility that there are independent effects of past overweight/obesity status 
on current HRQoL, which cannot be reversed through weight reduction. This again highlights 
the importance of primary prevention. Future research should focus on disentangling 
intentional and unintentional weight change, and the role of past overweight/obesity status on 
health outcomes. Further research is also needed to study the association in (young) children. 
The relative validation of the FFQ in Study II showed mixed results, which suggests the use of 
caution when measuring and interpreting food intake. Future validation studies may consider 
using an objective measurement to strengthen the interpretation of findings. Future research 
should also aim to identify new approaches to measuring dietary intake, given that traditional 
methods are known to be flawed. However, as Beaton stated as early as in 1994: “There is not, 
and probably never will be, a method that can estimate dietary intake without error” [152]. 
Therefore, future research should also look at how we can use existing methods, but 
appropriately identify and correct for errors in data collection and analysis [152]. 
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The results of Study III leave us with the question whether the intervention indeed did not work, 
or whether other factors (e.g., implementation or evaluation) could explain the absence of 
intervention effects. Therefore, future intervention studies should put more emphasis on 
process evaluation, including both quantitative and qualitative research. In addition, other 
(softer) outcome measures, e.g., feeding styles or children’s enjoyment, may add to current 
understanding of the causal pathway. 
As shown in Study IV and V, even small intervention effects may be worth the money. This, 
however, depends largely on the assumptions made and on the WTP of decision-makers. 
Currently, there are no thresholds for obesity-related outcomes, which may be an area for future 
research. In addition, or alternatively, more effort should be placed on the inclusion of QALY 
measures for children. Also, effect maintenance and spill-over effects (e.g., towards siblings) 
need to be further investigated. Furthermore, more research is needed on the direct (e.g., health 
care utilisation) and indirect (e.g., educational attainment) costs of obesity/overweight in 
childhood.  
6.8 CONCLUSION  
 
There was no evidence for the effectiveness or cost-effectiveness of the population-based 
PRIMROSE prevention trial conducted at Swedish CHCs. However, overweight and obesity 
significantly impact the HRQoL of individuals, and even if people with overweight reach 
normal weight, their HRQoL is worse than that of those with constant normal weight, which 
highlights the need for obesity prevention. Given that the obesity crisis persists, new 
approaches may be required, and further research needed, to disentangle the “failure” of 
intervention from the “failure” of implementation and the “failure” of evaluation.  
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